|
|
|
|
Document Preview Business Purchase Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Business Purchase Agreement |
|||
|
Entities: |
Galen Holdings plc; Genzyme Corp.; Schering-Plough Ltd.; Galen Limited; Pharmaceutical Development and Manufacturing Services Limited |
|||
|
Date: |
2003 |
|||
|
Size: |
Preview shows 7KB of 121KB total |
|||
|
Price: |
$54 |
|||
|
ID: |
#191253 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
[ASHURT MORRIS CRISP LOGO]
Business Purchase Agreement
Galen Limited
and
Pharmaceutical Development and Manufacturing Services
Limited
for the sale and purchase of the UK pharmaceutical
products manufacturing business and certain assets of
Galen Limited, a subsidiary of Galen Holdings Plc
2 December 2003
{PAGE}
CONTENTS
{TABLE}
{CAPTION}
CLAUSE PAGE
{S} {C}
INTERPRETATION...................................... 3
SALE AND PURCHASE................................... 10
CONSIDERATION....................................... 11
COMPLETION.......................................... 11
LIABILITIES......................................... 13
RECEIVABLES......................................... 14
CONTRACTS........................................... 15
STOCK AND INTERMEDIATES............................. 16
PREPAYMENTS BY SELLER AND CUSTOMERS................. 19
EMPLOYEES........................................... 21
FUTURE TRADING AND TRADE ENQUIRIES.................. 22
MHRA LICENCES....................................... 23
VALUE ADDED TAX..................................... 23
WARRANTIES.......................................... 24
PROTECTION OF GOODWILL.............................. 27
ANNOUNCEMENTS, ETC.................................. 29
ASSIGNMENT.......................................... 30
COSTS............................................... 30
ENTIRE AGREEMENT.................................... 30
WAIVER, AMENDMENT................................... 31
FURTHER ASSURANCE & ASSIGNMENT OF LEASES............ 31
NOTICES............................................. 33
COUNTERPARTS........................................ 35
GOVERNING LAW AND JURISDICTION...................... 35
INVALIDITY.......................................... 35
THIRD PARTY RIGHTS.................................. 36
SCHEDULE 1................................................
Allocation of Consideration...............................
SCHEDULE 2................................................
Warranties................................................
SCHEDULE 3................................................
Assumed Employees.........................................
SCHEDULE 4................................................
Contracts.................................................
SCHEDULE 5................................................
Galen Marketing Authorisations............................
SCHEDULE 6................................................
Properties................................................
SCHEDULE 7................................................
IT Equipment and Contracts................................
SCHEDULE 8................................................
Intermediate Valuation Policies and Procedures............
SCHEDULE 9................................................
Hire Purchase Agreements..................................
APPENDIX 1................................................
Lists of IT Equipment.....................................
APPENDIX 2................................................
Capital Grants............................................
{/TABLE}
{PAGE}
THIS AGREEMENT is made on 2 December 2003
BETWEEN:
(1) PHARMACEUTICAL DEVELOPMENT AND MANUFACTURING SERVICES LIMITED
(No. NI45055) whose registered office is at Almac House, 20 Seagoe
Industrial Estate, Craigavon, Northern Ireland BT63 5QD (the "BUYER");
and
(2) GALEN LIMITED (No. NI30077) whose registered office is at Unit 22,
Seagoe Industrial Estate, Craigavon, Co Armagh, Northern Ireland BT63
5UA (the "SELLER" or "GALEN").
RECITALS
(A) The Seller carries on the Business (as hereinafter defined) as part of
its group and is the beneficial owner, or is otherwise able to procure
the transfer, of the Assets (as hereinafter defined).
(B) The Seller has agreed to sell, and the Buyer has agreed to purchase,
the Business as a going concern and the Assets on the terms hereinafter
set out.
THE PARTIES AGREE AS FOLLOWS:
1. INTERPRETATION
1.1 The following words and expressions shall, unless the context otherwise
requires, have the following meanings:
"ACCOUNTS" means the audited financial statements (comprising a balance
sheet, profit and loss account, cash flow statement, notes and
directors' report and auditors' certificates) of the Seller for the
financial period ended on the Accounts Date in the Agreed Form;
"ACCOUNTS DATE" means 30 September 2002;
"AGREED FORM" means, in relation to a document, in the form agreed
between the parties on or prior to the date hereof and for the purposes
of identification signed on their behalf;
"ASSETS" means all assets, property or rights of the Seller relating to
or connected with or belonging to or used in the Business which shall,
without limitation include the Goodwill, Intermediates, Books and
Records, Contracts, Galen Marketing Authorisations, IT Equipment and
Assets, IT Contracts, Business Intellectual Property, Properties, Fixed
Plant and Loose Plant together with the assets and rights and the
benefit of any claims directly and exclusively relating to the
Business, other than the Excluded Assets;
"ASSIGNMENT" means the deed of assignment dated 31 March 2002 between
(1) Galen Limited and (2) Atoze Analytical Limited (3) Mairead Heron
and others and (4) Galen Holdings plc;
"ASSUMED CREDIT AMOUNT" means the capital payments outstanding as at
Completion to be made pursuant to the Hire Purchase Agreements as set
|
End of Preview |
Home Intelligence Services Subscriptions News About Us